Results 191 to 200 of about 171,375 (299)

Patients with refractory reflux symptoms often do not have GERD

open access: yesNeurogastroenterology and Motility, 2015
T. Herregods   +4 more
semanticscholar   +1 more source

Clarifying Terminology in Chronic Cough: The Evolving Role of Cough Hypersensitivity Syndrome

open access: yesThe Clinical Respiratory Journal, Volume 20, Issue 6, June 2026.
This review clarifies the definitions and relationships among ICC, UCC, and RCC, and introduces cough hypersensitivity syndrome (CHS) as an important pathophysiological framework for understanding chronic cough. Within this framework, CHS provides a mechanism‐based perspective that may complement existing terminology, guide future research, and improve
Zihang Wang   +8 more
wiley   +1 more source

Efficacy and Safety of Closure‐Focused Anti‐Reflux Mucoplasty Compared With Conventional ARMS: A Propensity Score–Matched Study (With Video)

open access: yesDigestive Endoscopy, Volume 38, Issue 6, June 2026.
ABSTRACT Background Endoscopic anti‐reflux therapies, including anti‐reflux mucosectomy (ARMS) and mucosal ablation (ARMA), offer minimally invasive treatment for gastroesophageal reflux disease (GERD) but carry risks of stenosis and delayed bleeding.
Kazuki Yamamoto   +9 more
wiley   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy